| pubmed-article:12759805 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12759805 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:12759805 | lifeskim:mentions | umls-concept:C0242948 | lld:lifeskim |
| pubmed-article:12759805 | lifeskim:mentions | umls-concept:C1882115 | lld:lifeskim |
| pubmed-article:12759805 | lifeskim:mentions | umls-concept:C0439825 | lld:lifeskim |
| pubmed-article:12759805 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:12759805 | pubmed:dateCreated | 2003-10-7 | lld:pubmed |
| pubmed-article:12759805 | pubmed:abstractText | Impaired auditory gating is common in schizophrenic patients. Evidence suggests that this deficit is related to a reduced number of alpha(7) nicotinic receptors and therefore treatment with alpha(7) nicotinic agonists may improve this condition. 3-(2,4)-Dimethoxybenzylidine anabaseine (DMXB; also known as GTS-21) is such an agonist and has shown efficacy in mice both orally and intraperitoneally. | lld:pubmed |
| pubmed-article:12759805 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12759805 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12759805 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12759805 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12759805 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12759805 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12759805 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12759805 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12759805 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12759805 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12759805 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:12759805 | pubmed:author | pubmed-author:StevensKaren... | lld:pubmed |
| pubmed-article:12759805 | pubmed:author | pubmed-author:KemWilliam... | lld:pubmed |
| pubmed-article:12759805 | pubmed:author | pubmed-author:O'NeillHeidi... | lld:pubmed |
| pubmed-article:12759805 | pubmed:author | pubmed-author:RiegerKateK | lld:pubmed |
| pubmed-article:12759805 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12759805 | pubmed:volume | 169 | lld:pubmed |
| pubmed-article:12759805 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12759805 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12759805 | pubmed:pagination | 332-9 | lld:pubmed |
| pubmed-article:12759805 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:meshHeading | pubmed-meshheading:12759805... | lld:pubmed |
| pubmed-article:12759805 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12759805 | pubmed:articleTitle | DMXB, an alpha7 nicotinic agonist, normalizes auditory gating in isolation-reared rats. | lld:pubmed |
| pubmed-article:12759805 | pubmed:affiliation | Department of Psychiatry C268-71, University of Colorado Health Sciences Center, 4200 East 9th Avenue,Denver, CO 80262, USA. | lld:pubmed |
| pubmed-article:12759805 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12759805 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12759805 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12759805 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12759805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12759805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12759805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12759805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12759805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12759805 | lld:pubmed |
